<<>>>
TitleUrlVersionPublisher
COVID19 ICD10CM Value Set for Loss of Sense of Smellhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.300420200715Clinical Architecture
COVID19 SNOMED Value Set for Arterial Blood Gases PaO2http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.602320200710Clinical Architecture
Mammographyhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.104720211201NCQA PHEMUR
Dopamine Blocking Agents (RX Norms)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.62820220520American Academy of Neurology Steward
Tobacco Use Cessation Counselinghttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.42520230215NCQA PHEMUR
Bronchiectasis Diagnosis SCThttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.146220220602HL7 Patient Care WG Steward
Congenital Absence of Cervixhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.113120180310NCQA PHEMUR
Post Acute Sequelae of Sars Cov 2 infection (PASC) ICD10http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.152920220726HL7 Patient Care WG Steward
Bleeding Disorderhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.28620230217Joint Commission
Isoxsuprinehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.116920170504NCQA PHEMUR
Cancer Medication Doxorubicinhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37220161227Oncology Nursing Society Steward
Counseling for Physical Activity CDShttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.30720240127MITRE Steward
Long Acting Inhaled Anticholinergicshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.5620180605Change Healthcare Steward
Distal Symmetric Polyneuropathy (DSP) (ICD9)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.53520201224American Academy of Neurology Steward
Acetaminophen / Dexbrompheniraminehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.140520170504NCQA PHEMUR
Intervention for Positive Housing Instability Screenhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2120240531Yale
Melioidosis (Disorders) (ICD10CM)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.129120210120CSTE Steward
S4G Malignant hyperthermiahttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.129420220826Elimu Informatics Steward
Limb Paralysis [Monoplegia and Diplegia] [Unspecified Cause] (Disorders) (ICD10CM)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.132820220119CSTE Steward
T Stage T2bhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.12620150820CancerLinQ Steward
Naegleria fowleri PAM (Tests for Naegleria fowleri Antigen)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.153920220118CSTE Steward
Lyme Disease (Tests for Borrelia burgdorferi/mayonii Nucleic Acid)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.85420220118CSTE Steward
Cardiopulmonary Arresthttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.404720230218Yale
Malignant Neoplasm of Respiratory and Intrathoracic Organshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.101020170826NCQA PHEMUR
Statin Allergenhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.4120220216TJC EH Steward
Influenza (Tests for influenza A or B virus Nucleic Acid)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.33620240123CSTE Steward
KCCQ Self Efficacy Scorehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.11.121320180310NCQA PHEMUR
Menopausehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.74820210915HL7 Patient Care WG Steward
PharmacyEducationhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.21420180911PharmacyHIT
Lymphedema Interventionhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.16820161227Oncology Nursing Society Steward
<<>>>774775776777778<<>>>